These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8206487)

  • 1. Monoclonal antibodies to detect breast cancer cells in bone marrow.
    Diel IJ; Kaufmann M; Costa SD; Bastert G
    Important Adv Oncol; 1994; ():143-64. PubMed ID: 8206487
    [No Abstract]   [Full Text] [Related]  

  • 2. Development and evaluation of monoclonal antibody-based immunoassays: breast carcinoma-associated mucins as tumor markers.
    Brown JP; Linsley PS; Horn D
    Immunol Ser; 1990; 53():69-82. PubMed ID: 1713071
    [No Abstract]   [Full Text] [Related]  

  • 3. Peptide epitopes in breast cancer mucins.
    Xing PX; Apostolopoulos V; Trapani J; Prenzoska J; McKenzie IF
    Adv Exp Med Biol; 1994; 353():9-16. PubMed ID: 7527180
    [No Abstract]   [Full Text] [Related]  

  • 4. [The role of epithelial antigens in diagnosis and staging of breast cancer].
    Artamonova EV; Tupitsyn NN; Kadagidze ZG; Letiagin VP; Ermilova VD; Ognerubov NA; Panichenko AV; Riazantseva SN
    Arkh Patol; 2002; 64(6):13-5. PubMed ID: 12534220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human models of breast cancer.
    Taylor-Papadimitriou J; Berdichevsky F; D'Souza B; Burchell J
    Cancer Surv; 1993; 16():59-78. PubMed ID: 8348539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative immunohistochemical studies of the histopathology of the breast using monoclonal antibodies Lu-5 and b-12].
    Förster C; Bässler R
    Pathologe; 1991 Mar; 12(2):60-5. PubMed ID: 1711692
    [No Abstract]   [Full Text] [Related]  

  • 7. Pancreatic tumor antigens: diagnostic markers and targets for immunotherapy.
    Finn OJ
    Important Adv Oncol; 1992; ():61-77. PubMed ID: 1374733
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunocytopathology of tumors of the breast. Test of 2 monoclonal antibodies on the products of cytologic aspiration of breast tumors and metastases].
    Anthonioz P
    J Gynecol Obstet Biol Reprod (Paris); 1986; 15(2):153-8. PubMed ID: 3522722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of bone marrow changes using marrow immunography].
    Carrió Gasset I; Berná Roqueta L
    Sangre (Barc); 1997 Aug; 42(4):295-9. PubMed ID: 9381286
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of a heterogeneous group of human breast carcinoma associated glycoproteins bearing the Tn determinant.
    Osinaga E; Pancino G; Porchet N; Berois N; De Cremoux P; Mistro D; Aubert JP; Calvo F; Roseto A
    Breast Cancer Res Treat; 1994; 32(2):139-52. PubMed ID: 7532464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative prognostic value of Cathepsin D and urokinase plasminogen activator, detected by immunohistochemistry, in primary breast carcinoma.
    Göhring UJ; Scharl A; Thelen U; Ahr A; Crombach G
    Anticancer Res; 1996; 16(2):1011-8. PubMed ID: 8687092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering of antibodies for breast cancer therapy: construction of chimeric and humanized versions of the murine monoclonal antibody BrE-3.
    Couto JR; Blank EW; Peterson JA; Kiwan R; Padlan EA; Ceriani RL
    Adv Exp Med Biol; 1994; 353():55-9. PubMed ID: 7985542
    [No Abstract]   [Full Text] [Related]  

  • 13. Breast mucin and associated antigens in diagnosis and therapy.
    Peterson JA; Ceriani RL
    Adv Exp Med Biol; 1994; 353():1-8. PubMed ID: 7527177
    [No Abstract]   [Full Text] [Related]  

  • 14. [Epithelial markers of 2 cytokeratin-negative small cell bronchial cancers].
    Bohrer MH; Hastka J
    Pathologe; 1991 Jan; 12(1):21-3. PubMed ID: 1708881
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of antibody responses to breast carcinoma associated mucins using synthetic peptide constructs as immunogens.
    Denton G; Sekowski M; Price MR
    Cancer Lett; 1993 Jul; 70(3):143-50. PubMed ID: 7689035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of detection of tumor cells in human bone marrow with or without prior culture.
    Joshi SS; Novak DJ; Messbarger L; Maitreyan V; Weisenburger DD; Sharp JG
    Bone Marrow Transplant; 1990 Sep; 6(3):179-83. PubMed ID: 2252957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivariate prognostic model for infiltrating ductal carcinoma of the breast in the axillary node-free patient.
    Ceriani RL; Baratta F; Gaslonde RJ; De Rosa CM; Ozzello L
    Adv Exp Med Biol; 1994; 353():155-67. PubMed ID: 7985534
    [No Abstract]   [Full Text] [Related]  

  • 18. [Breast cancer: prognostic value of a dissemination index based on 4 components of the urokinase-type plasminogen activator system].
    Bouchet C; Hacène K; Martin PM; Becette V; Tubiana-Hulin M; Lasry S; Oglobine J; Spyratos F
    Pathol Biol (Paris); 2000 Nov; 48(9):825-31. PubMed ID: 11141918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application?
    Lang JE; Hall CS; Singh B; Lucci A
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1463-72. PubMed ID: 17944570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of tumor-associated antigens in the biology and immunotherapy of breast cancer.
    Taylor-Papadimitriou J; D'Souza B; Burchell J; Kyprianou N; Berdichevsky F
    Ann N Y Acad Sci; 1993 Nov; 698():31-47. PubMed ID: 8279769
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.